A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in human epidermal growth factor receptor 2 positive (HER2+) early breast cancer (EBC) in China: Updated interim analysis from the NER-Tree study.Xiaojia Wang, Jin Zhang, Yuanqi Zhang et al.|Journal of Clinical Oncology|2025Cited by 0
Abstract P5-07-19: A multicenter, prospective, non-interventional study to investigate the treatment patterns of neratinib in Human Epidermal Growth Factor Receptor 2 positive (HER2+) early breast cancer (EBC) in China: NER-Tree study—An interim analysis on safetyJin Zhang, Xiaojia Wang, Haiguang Liu et al.|Clinical Cancer Research|2025Cited by 0